FindTrial
Sign In

XIENCE V® Everolimus Eluting Coronary Stent System (EECSS)

DEVICE2 trials

Sponsors

Abbott Medical Devices

Conditions

AngioplastyChronic Coronary OcclusionCoronary Artery DiseaseCoronary Artery StenosisCoronary DiseaseCoronary RestenosisMyocardial IschemiaStent Thrombosis

Unknown Phase

XIENCE V Everolimus Eluting Coronary Stent System (EECSS) China: Post-Approval, Single-Arm Study
CompletedNCT01249027
Abbott Medical DevicesAngioplasty, Chronic Coronary Occlusion, Coronary Artery Disease +6
Start: 2010-11-30End: 2017-01-31Updated: 2019-03-01
ABSORB PHYSIOLOGY Clinical Investigation
TerminatedNCT01308346
Abbott Medical DevicesCoronary Artery Disease
Start: 2011-11-30End: 2013-04-30Updated: 2013-05-07